NYSE : DOCS
Doximity, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 33.63 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.99B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Doximity, Inc. (DOCS) reported revenue of 655.57M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 655.57M | 644.86M | 570.40M | 475.42M | 419.05M | 343.55M |
| Cost of Revenue | 78.22M | 70.33M | 55.87M | 50.67M | 53.49M | 39.79M |
| Gross Profit | 577.34M | 574.54M | 514.52M | 424.75M | 365.56M | 303.76M |
| Selling, General & Admin | 234.54M | 222.03M | 190.70M | 170.96M | 159.51M | 127.62M |
| Research & Development | 142.38M | 130.70M | 93.04M | 81.98M | 80.19M | 62.35M |
| Operating Expenses | 376.92M | 352.73M | 283.74M | 252.94M | 239.70M | 189.97M |
| Operating Income | 200.43M | 221.81M | 230.78M | 171.81M | 125.87M | 113.79M |
| Interest & Investment Income | 32.78M | 35.70M | 35.85M | 21.66M | 9.29M | 2.15M |
| Other Non Operating Income (Expenses) | -857.00K | -806.00K | -247.00K | 62.00K | -146.00K | -448.00K |
| EBT Excluding Unusual Items | 232.35M | 256.70M | 266.39M | 193.54M | 135.01M | 115.49M |
| Merger & Restructuring Charges | -1.19M | -1.62M | -7.94M | -30.00K | -254.00K | |
| Gain (Loss) on Sale of Investments | 255.00K | 188.00K | 169.00K | -402.00K | -1.09M | -1.23M |
| Asset Writedown | -2.30M | |||||
| Legal Settlements | -4.85M | -4.85M | ||||
| Other Unusual Items | -339.00K | -417.00K | -680.00K | -728.00K | ||
| Pretax Income | 226.22M | 250.00M | 263.57M | 185.20M | 133.16M | 114.00M |
| Income Tax Expense | 59.17M | 53.95M | 40.39M | 37.62M | 20.34M | -40.78M |
| Net Income | 167.05M | 196.05M | 223.19M | 147.58M | 112.82M | 154.78M |
| Preferred Dividends & Other Adjustments | 21.53M | |||||
| Net Income to Common | 167.05M | 196.05M | 223.19M | 147.58M | 112.82M | 133.26M |
| Shares Outstanding (Basic) | 185.66M | 187.01M | 186.84M | 190.17M | 193.18M | 163.48M |
| Shares Outstanding (Diluted) | 196.55M | 199.05M | 201.21M | 205.73M | 213.43M | 191.02M |
| EPS (Basic) | 0.90 | 1.05 | 1.19 | 0.78 | 0.58 | 0.82 |
| EPS (Diluted) | 0.84 | 0.98 | 1.11 | 0.72 | 0.53 | 0.70 |
| Free Cash Flow | 306.28M | 326.46M | 273.26M | 183.95M | 177.90M | 124.66M |
| Free Cash Flow Per Share | 1.56 | 1.64 | 1.36 | 0.89 | 0.83 | 0.65 |
| Gross Margin | 88.07% | 89.09% | 90.20% | 89.34% | 87.23% | 88.42% |
| Operating Margin | 30.57% | 34.40% | 40.46% | 36.14% | 30.04% | 33.12% |
| Profit Margin | 25.48% | 30.40% | 39.13% | 31.04% | 26.92% | 38.79% |
| Free Cash Flow Margin | 46.72% | 50.62% | 47.91% | 38.69% | 42.45% | 36.29% |
| EBITDA | 208.40M | 228.79M | 235.64M | 177.08M | 131.35M | 115.33M |
| EBITDA Margin | 31.79% | 35.48% | 41.31% | 37.25% | 31.34% | 33.57% |
| D&A For EBITDA | 7.98M | 6.98M | 4.86M | 5.26M | 5.48M | 1.54M |
| EBIT | 200.43M | 221.81M | 230.78M | 171.81M | 125.87M | 113.79M |
| EBIT Margin | 30.57% | 34.40% | 40.46% | 36.14% | 30.04% | 33.12% |
| Effective Tax Rate | 26.16% | 21.58% | 15.32% | 20.31% | 15.27% | |
| Advertising Expenses | 3.90M | 2.60M | 2.50M | 2.60M | 2.80M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 273.60M | 219.18M | 209.61M | 96.78M | 158.03M | 112.81M |
| Short-Term Investments | 414.19M | 529.42M | 706.05M | 666.12M | 682.97M | 685.30M |
| Cash & Short-Term Investments | 687.79M | 748.60M | 915.66M | 762.90M | 841.00M | 798.11M |
| Accounts Receivable | 179.28M | 146.98M | 130.05M | 103.63M | 109.25M | 82.47M |
| Other Receivables | 4.40M | 5.30M | 5.80M | 3.80M | 2.80M | 2.10M |
| Receivables | 183.68M | 152.28M | 135.85M | 107.43M | 112.05M | 84.57M |
| Prepaid Expenses | 36.11M | 35.38M | 30.10M | 37.61M | 22.41M | 15.94M |
| Other Current Assets | 6.40M | 8.00M | 7.00M | 5.00M | 5.51M | |
| Total Current Assets | 913.98M | 944.26M | 1.09B | 912.94M | 975.45M | 904.14M |
| Property, Plant & Equipment | 26.00M | 25.22M | 22.54M | 24.65M | 25.10M | 9.57M |
| Goodwill | 84.97M | 84.97M | 67.94M | 67.94M | 67.94M | 18.91M |
| Other Intangible Assets | 33.38M | 35.33M | 23.07M | 27.32M | 31.84M | 7.91M |
| Long-Term Deferred Tax Assets | 23.84M | 31.98M | 60.01M | 45.07M | 34.91M | 48.56M |
| Long-Term Deferred Charges | 500.00K | 600.00K | 500.00K | 400.00K | ||
| Other Long-Term Assets | 1.18M | 1.32M | 1.62M | 1.06M | 1.65M | 2.26M |
| Total Assets | 1.08B | 1.12B | 1.26B | 1.08B | 1.14B | 991.36M |
| Accounts Payable | 6.49M | 4.01M | 1.36M | 2.25M | 1.27M | 463.00K |
| Accrued Expenses | 23.39M | 26.17M | 26.93M | 18.39M | 19.91M | 21.01M |
| Current Portion of Leases | 2.14M | 2.11M | 2.21M | 2.15M | 1.75M | 642.00K |
| Current Income Taxes Payable | 4.61M | 1.79M | ||||
| Current Unearned Revenue | 109.06M | 106.05M | 114.28M | 99.14M | 105.24M | 84.91M |
| Other Current Liabilities | 4.66M | 14.84M | 11.47M | 25.32M | 11.33M | 4.26M |
| Total Current Liabilities | 150.36M | 154.97M | 156.26M | 147.25M | 139.51M | 111.28M |
| Long-Term Leases | 7.53M | 8.07M | 10.19M | 12.40M | 13.88M | 447.00K |
| Long-Term Unearned Revenue | 37.00K | 400.00K | 280.00K | 211.00K | 198.00K | 78.00K |
| Other Long-Term Liabilities | 9.84M | 9.40M | 14.96M | 18.12M | 17.18M | 956.00K |
| Total Liabilities | 167.78M | 172.85M | 181.68M | 177.98M | 170.77M | 112.76M |
| Common Stock | 180.00K | 183.00K | 189.00K | 187.00K | 194.00K | 192.00K |
| Additional Paid-In Capital | 1.04B | 1.00B | 894.23M | 823.88M | 762.15M | 702.59M |
| Retained Earnings | -119.04M | -51.06M | 186.89M | 79.99M | 217.85M | 191.11M |
| Comprehensive Income & Other | -348.00K | 28.00K | 1.32M | -2.66M | -14.08M | -15.29M |
| Total Common Equity | 916.07M | 950.84M | 1.08B | 901.40M | 966.12M | 878.59M |
| Shareholders' Equity | 916.07M | 950.84M | 1.08B | 901.40M | 966.12M | 878.59M |
| Total Liabilities & Equity | 1.08B | 1.12B | 1.26B | 1.08B | 1.14B | 991.36M |
| Total Debt | 9.67M | 10.19M | 12.40M | 14.55M | 15.64M | 1.09M |
| Net Cash (Debt) | 678.12M | 738.42M | 903.27M | 748.35M | 825.36M | 797.02M |
| Net Cash Per Share | 3.45 | 3.71 | 4.49 | 3.64 | 3.87 | 4.17 |
| Filing Date Shares Outstanding | 178.25M | 182.87M | 187.83M | 185.43M | 194.67M | 193.11M |
| Total Common Shares Outstanding | 179.85M | 183.06M | 188.88M | 186.56M | 193.94M | 192.40M |
| Working Capital | 763.62M | 789.29M | 932.36M | 765.69M | 835.95M | 792.86M |
| Book Value Per Share | 5.09 | 5.19 | 5.73 | 4.83 | 4.98 | 4.57 |
| Tangible Book Value | 797.71M | 830.54M | 991.61M | 806.14M | 866.34M | 851.77M |
| Tangible Book Value Per Share | 4.44 | 4.54 | 5.25 | 4.32 | 4.47 | 4.43 |
| Machinery | 2.33M | 2.27M | 2.83M | 3.58M | 3.56M | 1.10M |
| Leasehold Improvements | 816.00K | 816.00K | 816.00K | 992.00K | 888.00K | 796.00K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | 167.05M | 196.05M | 223.19M | 147.58M | 112.82M | 154.78M |
| Depreciation & Amortization | 7.98M | 6.98M | 4.86M | 5.26M | 5.48M | 1.54M |
| Other Amortization | 21.78M | 20.88M | 15.77M | 13.87M | 13.59M | 13.26M |
| Asset Writedown & Restructuring Costs | 2.30M | |||||
| Loss (Gain) From Sale of Investments | -5.66M | -7.58M | -11.65M | -5.24M | 3.12M | 5.56M |
| Stock-Based Compensation | 136.51M | 121.63M | 72.39M | 51.08M | 47.83M | 31.44M |
| Other Operating Activities | 34.21M | 34.20M | -9.48M | -3.94M | 17.80M | -39.68M |
| Change in Accounts Receivable | -36.83M | -16.88M | -27.21M | 3.99M | -26.24M | -31.02M |
| Change in Accounts Payable | 2.00M | 4.27M | -663.00K | 8.33M | -195.00K | 8.66M |
| Change in Unearned Revenue | -8.44M | -8.12M | 15.21M | -6.08M | 17.53M | 1.83M |
| Change in Other Net Operating Assets | -12.25M | -24.97M | -11.44M | -30.77M | -12.12M | -19.80M |
| Operating Cash Flow | 306.34M | 326.46M | 273.26M | 184.10M | 179.60M | 126.58M |
| Capital Expenditures | -62.00K | -147.00K | -1.70M | -1.91M | ||
| Cash Acquisitions | -26.53M | -26.53M | -53.50M | |||
| Sale (Purchase) of Intangibles | -9.32M | -8.96M | -6.53M | -5.65M | -4.48M | -3.79M |
| Investment in Securities | 293.39M | 182.66M | -22.77M | 36.99M | -239.00K | -635.47M |
| Other Investing Activities | 595.00K | |||||
| Investing Cash Flow | 257.48M | 147.17M | -29.30M | 31.19M | -59.92M | -640.57M |
| Issuance of Common Stock | 14.36M | 13.68M | 23.30M | 16.34M | 14.69M | 567.91M |
| Repurchase of Common Stock | -436.82M | -472.49M | -148.97M | -287.47M | -89.15M | -3.52M |
| Other Financing Activities | -5.02M | -5.25M | -5.47M | -5.39M | -3.98M | |
| Financing Cash Flow | -427.48M | -464.06M | -131.14M | -276.52M | -74.46M | 560.41M |
| Net Cash Flow | 136.34M | 9.56M | 112.83M | -61.24M | 45.22M | 46.42M |
| Free Cash Flow | 306.28M | 326.46M | 273.26M | 183.95M | 177.90M | 124.66M |
| Free Cash Flow Margin | 46.72% | 50.62% | 47.91% | 38.69% | 42.45% | 36.29% |
| Free Cash Flow Per Share | 1.56 | 1.64 | 1.36 | 0.89 | 0.83 | 0.65 |
| Levered Free Cash Flow | 239.70M | 255.26M | 216.76M | 163.55M | 138.07M | 82.07M |
| Unlevered Free Cash Flow | 239.70M | 255.26M | 216.76M | 163.55M | 138.07M | 82.07M |
| Cash Income Tax Paid | 20.83M | 21.81M | 55.65M | 51.27M | 5.23M | 206.00K |
| Change in Working Capital | -55.52M | -45.70M | -24.10M | -24.52M | -21.03M | -40.33M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.84B | 4.30B | 10.89B | 5.02B | 6.27B | 9.97B |
| Enterprise Value | 5.16B | 3.58B | 10.06B | 4.32B | 5.48B | 9.20B |
| Last Close Price | 32.76 | 23.30 | 58.03 | 26.91 | 32.38 | 52.09 |
| PE Ratio | 38.88 | 21.95 | 48.79 | 34.02 | 55.56 | 74.78 |
| Forward PE | 22.98 | 15.04 | 42.92 | 29.34 | 43.81 | 82.17 |
| PS Ratio | 8.91 | 6.67 | 19.09 | 10.56 | 14.96 | 29.01 |
| PB Ratio | 6.43 | 4.53 | 10.06 | 5.57 | 6.49 | 11.34 |
| P/TBV Ratio | 7.32 | 5.18 | 10.98 | 6.23 | 7.24 | 11.70 |
| P/FCF Ratio | 19.07 | 13.18 | 39.85 | 27.29 | 35.24 | 79.94 |
| P/OCF Ratio | 19.06 | 13.18 | 39.85 | 27.27 | 34.90 | 78.73 |
| PEG Ratio | 13.33 | 0.94 | 2.32 | 2.85 | 13.05 | 10.99 |
| EV/Sales Ratio | 7.87 | 5.55 | 17.63 | 9.10 | 13.09 | 26.78 |
| EV/EBITDA Ratio | 24.77 | 15.64 | 42.68 | 24.42 | 41.74 | 79.78 |
| EV/EBIT Ratio | 25.75 | 16.14 | 43.58 | 25.17 | 43.56 | 80.86 |
| EV/FCF Ratio | 16.85 | 10.96 | 36.80 | 23.51 | 30.82 | 73.81 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Debt / EBITDA Ratio | 0.05 | 0.04 | 0.05 | 0.08 | 0.12 | 0.01 |
| Debt / FCF Ratio | 0.03 | 0.03 | 0.04 | 0.08 | 0.09 | 0.01 |
| Net Debt / Equity Ratio | -0.74 | -0.78 | -0.83 | -0.83 | -0.85 | -0.91 |
| Net Debt / EBITDA Ratio | -3.25 | -3.23 | -3.83 | -4.23 | -6.28 | -6.91 |
| Net Debt / FCF Ratio | -2.21 | -2.26 | -3.31 | -4.07 | -4.64 | -6.39 |
| Asset Turnover | 0.57 | 0.54 | 0.49 | 0.43 | 0.39 | 0.55 |
| Quick Ratio | 5.80 | 5.81 | 6.73 | 5.91 | 6.83 | 7.93 |
| Current Ratio | 6.08 | 6.09 | 6.97 | 6.20 | 6.99 | 8.12 |
| Return on Equity (ROE) | 17.21% | 19.28% | 22.50% | 15.80% | 12.23% | 30.15% |
| Return on Assets (ROA) | 10.95% | 11.61% | 12.31% | 9.69% | 7.39% | 11.44% |
| Return on Invested Capital (ROIC) | 65.72% | 88.79% | 117.58% | 93.20% | 95.93% | 139.50% |
| Return on Capital Employed (ROCE) | 21.50% | 22.90% | 20.80% | 18.40% | 12.60% | 12.90% |
| Earnings Yield | 2.57% | 4.55% | 2.05% | 2.94% | 1.80% | 1.55% |
| FCF Yield | 5.25% | 7.58% | 2.51% | 3.66% | 2.84% | 1.25% |
| Buyback Yield / Dilution | 2.55% | 1.07% | 2.20% | 3.60% | -11.73% | -100.79% |